UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Diabetologia, 2005-09, Vol.48 (9), p.1716-1725

2005

Volltextzugriff (PDF)

National Prevalence of Obesity: Prevalence of obesity in Poland

Obesity reviews, 2005-05, Vol.6 (2), p.113-114

2005

Volltextzugriff (PDF)

Prevalence of obesity in Poland

Obesity reviews, 2005-05, Vol.6 (2), p.113-114

2005

Volltextzugriff (PDF)

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Diabetic medicine, 2009-03, Vol.26 (3), p.268-278

2009

Volltextzugriff (PDF)

Health status of the children of diabetic mothers

Journal of Pediatric Endocrinology and Metabolism, 2001, Vol.14 Suppl 1 (Supplement), p.691

2001

Volltextzugriff (PDF)

Tesaglitazar (GALIDA(TM)) Improves Postprandial Lipid Handling and Glucose Tolerance in an Insulin-Resistant, Non-Diabetic Population

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A152

2005

Volltextzugriff (PDF)

Glucose tolerance and insulin secretion during treatment of hyperthyroidism

Endokrynologia polska, 1980-05, Vol.31 (3), p.241

Lopatyński, J

1980

Volltextzugriff (PDF)

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor [alpha]/[gamma] agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Diabetologia, 2005-09, Vol.48 (9), p.1716

2005

Volltextzugriff (PDF)

High density lipoprotein cholesterol (HDL-Ch) during treatment of hyperthyroidism

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1980-09, Vol.35 (38), p.1449

Lopatyński, J

1980

Volltextzugriff (PDF)

The inquiry into the purposes of carelessness in out-patient treatment of arterial hypertension (author's transl)

Przeglad lekarski, 1977, Vol.34 (3), p.345

1977

Volltextzugriff (PDF)

Studies on the lipid metabolism indicators, glucose tolerance and insulin and glucagon secretion during conservative treatment of thyrotoxicosis. Summary of the thesis

Endokrynologia polska, 1981-05, Vol.32 (3), p.285

Lopatyński, J

1981

Volltextzugriff (PDF)

Alterations in serum HDL and LDL cholesterol during antithyroid treatment

Endokrynologia polska, 1981-09, Vol.32 (5), p.415

1981

Volltextzugriff (PDF)

Evaluation of efficacy, safety and tolerance of glimepiride (Amaryl) in patients with type 2 diabetes

Przeglad lekarski, 2000, Vol.57 Suppl 4, p.23

2000

Volltextzugriff (PDF)

Antiorgan antibodies in rabbits fed atherogenic diet

Archivum Immunologiae et Therapiae Experimentalis, 1972, Vol.20 (4), p.485-489

1972

Volltextzugriff (PDF)

The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)

Polskie archiwum medycyny wewne̦trznej, 2001-09, Vol.106 (3), p.781

2001

Volltextzugriff (PDF)

Studies of the chemical composition of the aortic wall. V. Effect of Atromid S on some fractions of collagen in the aortic wall of rats fed an atherogenic diet

Polish medical science and history bulletin, 1967-01, Vol.10 (1), p.24

1967

Volltextzugriff (PDF)

Studies on the chemical composition of vascular walls. IX. Effect of experimentally induced arterial hypertension and atherogenic diet on certain protein fractions of the aortic wall

Polskie archiwum medycyny wewne̦trznej, 1968, Vol.40 (4), p.431

Lopatyński, J

1968

Volltextzugriff (PDF)

The effect of experimental hypertension and atherogenic diet on the content of cholesterol in the aorta wall and on the level of lipids in the serum

Annales Universitatis Mariae Curie-Skłodowska. Sectio D, Medicina, 1968, Vol.23, p.55

Lopatyński, J

1968

Volltextzugriff (PDF)

Diabetes mellitus and thyroid diseases

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1980-04, Vol.35 (16), p.591

Lopatyński, J

1980

Volltextzugriff (PDF)

The effect of atherogenic diet and experimental alloxan-induced diabetes on serum levels of proteins, glucose, and lipids in rabbits

Acta physiologica Polonica, 1974-11, Vol.25 (6), p.547

1974

Volltextzugriff (PDF)

Use of beta-adrenolytics in the treatment of thyrotoxicosis

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1987-09, Vol.42 (36), p.1099

1987

Volltextzugriff (PDF)

Pulmonary function between 40 and 80 years of age

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2005-09, Vol.56 Suppl 4, p.127

2005

Volltextzugriff (PDF)

Glucose tolerance and insulin secretion in patients with thyrotoxicosis treated with propranolol

Przeglad lekarski, 1984, Vol.41 (5), p.365

1984

Volltextzugriff (PDF)

Propranolol in the treatment of thyreotoxicosis

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1979-02, Vol.34 (7), p.265

1979

Volltextzugriff (PDF)

Arterial hypertension as a risk factor in the development of arteriosclerosis

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1974-04, Vol.29 (17), p.747

1974

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(6)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

6 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

National Prevalence of Obesity: Prevalence of obesity in Poland

Prevalence of obesity in Poland

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Health status of the children of diabetic mothers

Tesaglitazar (GALIDA(TM)) Improves Postprandial Lipid Handling and Glucose Tolerance in an Insulin-Resistant, Non-Diabetic Population

Glucose tolerance and insulin secretion during treatment of hyperthyroidism

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor [alpha]/[gamma] agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

High density lipoprotein cholesterol (HDL-Ch) during treatment of hyperthyroidism

The inquiry into the purposes of carelessness in out-patient treatment of arterial hypertension (author's transl)

Studies on the lipid metabolism indicators, glucose tolerance and insulin and glucagon secretion during conservative treatment of thyrotoxicosis. Summary of the thesis

Alterations in serum HDL and LDL cholesterol during antithyroid treatment

Evaluation of efficacy, safety and tolerance of glimepiride (Amaryl) in patients with type 2 diabetes

Antiorgan antibodies in rabbits fed atherogenic diet

The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)

Studies of the chemical composition of the aortic wall. V. Effect of Atromid S on some fractions of collagen in the aortic wall of rats fed an atherogenic diet

Studies on the chemical composition of vascular walls. IX. Effect of experimentally induced arterial hypertension and atherogenic diet on certain protein fractions of the aortic wall

The effect of experimental hypertension and atherogenic diet on the content of cholesterol in the aorta wall and on the level of lipids in the serum

Diabetes mellitus and thyroid diseases

The effect of atherogenic diet and experimental alloxan-induced diabetes on serum levels of proteins, glucose, and lipids in rabbits

Use of beta-adrenolytics in the treatment of thyrotoxicosis

Pulmonary function between 40 and 80 years of age

Glucose tolerance and insulin secretion in patients with thyrotoxicosis treated with propranolol

Propranolol in the treatment of thyreotoxicosis

Arterial hypertension as a risk factor in the development of arteriosclerosis

Suchergebnisse filtern